Strobeck Matthew 4

What Happened
Matthew Strobeck, a director of QuidelOrtho Corp (QDEL), acquired 10,000 shares in open-market/private purchases on February 13, 2026. The weighted average purchase price was $23.9586 per share (range $23.7600–$23.9999), for an aggregate purchase cost of approximately $239,586. This was a buy (P) rather than a sale.

Key Details

• Transaction date: 2026-02-13.
• Transaction type/code: Open market or private purchase (P).
• Price: Weighted average $23.9586; range $23.7600–$23.9999 per share.
• Shares acquired: 10,000; total ≈ $239,586.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes of note:
  • F1: Reporting person will provide on request the number of shares purchased at each separate price.
  • F2: Strobeck is custodian under the Uniform Gift to Minor Act for 16,630 shares held by four of his children and disclaims beneficial ownership of those shares.
  • F3: Strobeck has sole voting and dispositive power over shares held by Birchview Fund, LLC as Managing Partner and disclaims beneficial ownership except to the extent of any pecuniary interest.
• Timeliness: Filing and transaction are dated the same day (2026-02-13); no late filing indicated in the provided data.

Context
This was a straight open-market purchase (not an option exercise, award, or gift). Purchases by insiders are often watched by investors as one data point on insider sentiment, but the filing does not state the insider’s motivation. Note the filing includes custodial and fund-related disclosures that clarify legal control versus asserted beneficial ownership.